Compile Data Set for Download or QSAR
maximum 50k data
Found 19 Enz. Inhib. hit(s) with all data for entry = 50011832
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111082(9-Chloro-2-phenyl-3,4,5,6-tetrahydro-1,3-diaza-ben...)
Affinity DataIC50:  1.70nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111079(9-Methyl-2-pyridin-3-yl-3,4,5,6-tetrahydro-1,3-dia...)
Affinity DataIC50:  2.30nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111085(2-Phenyl-3,4,5,6-tetrahydro-1,3-diaza-benzo[e]azul...)
Affinity DataIC50:  5.80nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111083(9-Methoxy-2-pyridin-3-yl-3,4,5,6-tetrahydro-1,3-di...)
Affinity DataIC50:  6.30nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111089(9-Methyl-2-pyridin-4-yl-3,4,5,6-tetrahydro-1,3-dia...)
Affinity DataIC50:  6.40nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111092(9-Fluoro-2-pyridin-3-yl-3,4,5,6-tetrahydro-1,3-dia...)
Affinity DataIC50:  6.40nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111094(2-Pyridin-3-yl-3,4,5,6-tetrahydro-1,3-diaza-benzo[...)
Affinity DataIC50:  7.30nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111095(9-Methoxy-2-pyridin-4-yl-3,4,5,6-tetrahydro-1,3-di...)
Affinity DataIC50:  13nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111080(9-Fluoro-2-pyridin-4-yl-3,4,5,6-tetrahydro-1,3-dia...)
Affinity DataIC50:  13nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111081(2-Pyridin-4-yl-3,4,5,6-tetrahydro-1,3-diaza-benzo[...)
Affinity DataIC50:  20nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111096(9-Methoxy-2-phenyl-3,4,5,6-tetrahydro-1,3-diaza-be...)
Affinity DataIC50:  25nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111078(9-Methyl-2-pyridin-2-yl-3,4,5,6-tetrahydro-1,3-dia...)
Affinity DataIC50:  32nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111088(9-Fluoro-2-pyridin-2-yl-3,4,5,6-tetrahydro-1,3-dia...)
Affinity DataIC50:  46nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111090(8-Methoxy-2-phenyl-4,5-dihydro-3H-naphtho[1,2-d]im...)
Affinity DataIC50:  52nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111087(9-Methoxy-2-pyridin-2-yl-3,4,5,6-tetrahydro-1,3-di...)
Affinity DataIC50:  110nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111091(2-Pyridin-2-yl-3,4,5,6-tetrahydro-1,3-diaza-benzo[...)
Affinity DataIC50:  110nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111086(3-(5-Methyl-2-phenyl-1H-imidazol-4-yl)-pyridine | ...)
Affinity DataIC50:  427nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111093(2-(1H-Imidazol-4-yl)-3,4,5,6-tetrahydro-1,3-diaza-...)
Affinity DataIC50:  570nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111084(2-Phenyl-4,5-dihydro-3H-6-oxa-1,3-diaza-benzo[e]az...)
Affinity DataIC50:  6.10E+3nMAssay Description:Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed